SCHEMBL4865308

SCHEMBL4865308

Cc1cc2ccccc2n1-c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
SLC6A2 P23975 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
XBP1 P17861 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.40
MAT2A P31153 2/20 0.40
RAB9A P51151 1/20 0.40
MAPK14 Q16539 1/20 0.39
CYP17A1 P05093 2/20 0.39
CYP1A2 P05177 2/20 0.39
S1PR4 O95977 1/20 0.38
GAA P10253 1/20 0.38
DPP4 P27487 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29387435 1.00 SMN1; SMN2 (0.43) SMN1; SMN2KDM4EALDH1A1SLC6A2MEN1
SCHEMBL29155265 0.89 POLB (0.38) SMN1; SMN2KDM4EALDH1A1SLC6A2MEN1
SCHEMBL29134581 0.83 MAPK14 (0.40) SMN1; SMN2KDM4EALDH1A1MEN1NPC1
SCHEMBL29134984 0.83 MAT2A (0.50) SMN1; SMN2KDM4EALDH1A1MEN1NPC1
SCHEMBL30704300 0.83 MAPK14 (0.40) SMN1; SMN2KDM4EALDH1A1MEN1NPC1
SCHEMBL30704311 0.83 MAT2A (0.50) SMN1; SMN2KDM4EALDH1A1MEN1NPC1
SCHEMBL28492642 0.82 SLC6A2 (0.45) KDM4EALDH1A1SLC6A2MAPTKMT2A
SCHEMBL30724191 0.79 POLB (0.41) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL30724190 0.79 POLB (0.41) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL29408795 0.79 POLB (0.41) SMN1; SMN2KDM4EALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117343044-A Synthesis method of 2-methyl-1- (pyridine-2-yl) indole compound 太原理工大学 2024-01-05 CN claimed
CN-117343043-A Synthesis method of 2-tridentate methyl-1- (pyridine-2-yl) indole compound 山西天宏达安医药科技有限公司 2024-01-05 CN claimed
CN-117384133-A 2-bromo-1- (pyridin-2-yl) indole compound and preparation method thereof 内蒙古益泽制药有限公司 2024-01-12 CN disclosed
CN-117343044-A Synthesis method of 2-methyl-1- (pyridine-2-yl) indole compound 太原理工大学 2024-01-05 CN disclosed
CN-117343043-A Synthesis method of 2-tridentate methyl-1- (pyridine-2-yl) indole compound 山西天宏达安医药科技有限公司 2024-01-05 CN disclosed
CN-117343044-A Synthesis method of 2-methyl-1- (pyridine-2-yl) indole compound 太原理工大学 2024-01-05 CN disclosed
CN-117343093-A Synthesis method of iron-catalyzed non-activated gem difluoro-bialkylene compound double-silicon-based 山西天宏达安医药科技有限公司 2024-01-05 CN disclosed
CN-117343044-A Synthesis method of 2-methyl-1- (pyridine-2-yl) indole compound 太原理工大学 2024-01-05 CN disclosed
CN-117343043-A Synthesis method of 2-tridentate methyl-1- (pyridine-2-yl) indole compound 山西天宏达安医药科技有限公司 2024-01-05 CN disclosed
CN-117343043-A Synthesis method of 2-tridentate methyl-1- (pyridine-2-yl) indole compound 山西天宏达安医药科技有限公司 2024-01-05 CN disclosed
CN-1609101-B Organometallic complex and light-emitting element containing the same SEMICONDUCTOR ENERGY LAB 2010-05-26 CN disclosed
US-7314769-B2 Organometallic complex and light-emitting element containing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-01-01 US disclosed
US-6998492-B2 Organometallic complex and light-emitting element containing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2006-02-14 US disclosed
CN-1609101-A Organometallic complex and light-emitting element containing the same SEMICONDUCTOR ENERGY LAB (JP) 2005-04-27 CN disclosed
US-20050033054-A1 Organometallic complex and light-emitting element containing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2005-02-10 US disclosed
US-20040230061-A1 Organometallic complex and light-emitting element containing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033054-A1 Organometallic complex and light-emitting element containing the same BCKDK, CCNK, CDK20 SMN1; SMN2 4825/4885KDM4E 463/4885ALDH1A1 355/4885
US-20040230061-A1 Organometallic complex and light-emitting element containing the same NR0B1, BCKDK, NR4A1 SMN1; SMN2 4808/4885KDM4E 384/4885ALDH1A1 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.